O'Shaughnessy Asset Management’s Evolent Health EVH Stock Holding History

O'Shaughnessy Asset Management’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-9,364	Closed	-$336K	–	1413
2022 Q3	$336K	Buy	+9,364	New	+$330K	0.01%	888
2021 Q4	–	Sell	-3,226	Closed	-$100K	–	1628
2021 Q3	$100K	Buy	3,226 +2,634	+445%	+$63.2K	﹤0.01%	1369
2021 Q2	$12K	Hold	592	–	–	﹤0.01%	1964
2021 Q1	$12K	Buy	+592	New	+$11.3K	﹤0.01%	1749

Other funds holding EVH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

O'Shaughnessy Asset Management's EVH Position: Q4 2022 in Review

O'Shaughnessy Asset Management sold out of Evolent Health (EVH) in Q4 2022, closing a stake of 9,364 shares — an estimated $336K sold.

O'Shaughnessy Asset Management first reported a position in EVH in Q1 2021 and held it in 4 quarters. The position peaked at $336K in Q3 2022. 232 funds tracked by Wall St. Rank hold EVH as of Q4 2022.

O'Shaughnessy Asset Management reported no remaining Evolent Health position as of Q4 2022 after selling out during the quarter.
O'Shaughnessy Asset Management sold 9,364 Evolent Health shares in Q4 2022, an estimated $336K.
O'Shaughnessy Asset Management first reported a position in Evolent Health in Q1 2021 and held it in 4 quarters.
O'Shaughnessy Asset Management's Evolent Health position peaked at $336K in Q3 2022.
232 funds tracked by Wall St. Rank held Evolent Health as of Q4 2022.

Based on O'Shaughnessy Asset Management's 13F filing for Q4 2022, filed 10 Feb 2023.